Journal of the Korean Medical Association (대한의사협회지)

Korean Medical Association (대한의사협회)
권호 표지
DOI QR코드

DOI QR Code

Clinical practice guideline for dementia by Clinical Research Center for Dementia of South Korea

한국형 치매임상진료지침 소개

  • Ku, Bon D. (Department of Neurology, Myongji Hospital, Kwandong University College of Medicine) ;
  • Kim, Shin Gyeom (Department of Psychiatry, Bucheon Hospital, Soonchunhyang University College of Medicine) ;
  • Lee, Jun-Young (Department of Psychiatry, Boramae Hospital, Seoul National University College of Medicine) ;
  • Park, Kee Hyung (Department of Neurology, Gil Hospital, Gachon University of Medicine and Science) ;
  • Shin, Joon Hyun (Department of Neurology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Kim, Kwang Ki (Department of Neurology, Ilsan Hospital, Dongguk University School of Medicine) ;
  • Youn, Young Chul (Department of Neurology, Chung-Ang University College of Medicine) ;
  • Lee, Yung Min (Department of Psychiatry, Busan National University School of Medicine) ;
  • Hong, Chang Hyung (Department of Psychiatry, Ajou University School of Medicine) ;
  • Seo, Sang Won (Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Na, Duk L. (Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Sung Yoon (Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Cheong, Hae-Kwan (Department of Social and Preventive Medicine, Sungkyunkwan University College of Medicine) ;
  • Kim, Doh Kwan (Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University College of Medicine) ;
  • Lee, Jae-Hong (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, SangYun (Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Yeon, Byeong Kil (Department of Psychiatry, Kangdong Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Kim, Soo Young (Department of Family Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Han, Seol-Heui (Department of Neurology, Konkuk University Medical Center, Konkuk University School of Medicine)
  • 구본대 (관동대학교 의과대학 명지병원 신경과) ;
  • 김신겸 (순천향대학교 의과대학 부천병원 정신과) ;
  • 이준영 (서울대학교 의과대학 보라매병원 정신과) ;
  • 박기형 (가천의과학대학 길병원 신경과) ;
  • 신준현 (한림대학교 의과대학 강동성심병원 신경과) ;
  • 김광기 (동국대학교 의학전문대학원 일산병원 신경과) ;
  • 윤영철 (중앙대학교 의과대학 신경과학교실) ;
  • 이영민 (부산대학교 의과대학 정신과학교실) ;
  • 홍창형 (아주대학교 의과대학 정신과학교실) ;
  • 서상원 (성균관대학교 의과대학 삼성서울병원 신경과) ;
  • 나덕렬 (성균관대학교 의과대학 삼성서울병원 신경과) ;
  • 김성윤 (울산대학교 의과대학 서울아산병원 정신과) ;
  • 정해관 (성균관대학교 의과대학 사회의학교실) ;
  • 김도관 (성균관대학교 의과대학 삼성서울병원 정신과) ;
  • 이재홍 (울산대학교 의과대학 서울아산병원 신경과) ;
  • 김상윤 (서울대학교 의과대학 분당서울대병원 신경과) ;
  • 연병길 (한림대학교 의과대학 강동성심병원 정신과) ;
  • 김수영 (한림대학교 의과대학 강동성심병원 가정의학과) ;
  • 한설희 (건국대학교 의학전문대학원 건국대학교병원 신경과)
  • Published : 2011.08.10
⟨ Previous Next ⟩

Abstract

The Clinical Research Center for Dementia of South Korea (CREDOS), a nation-wide clinical dementia research group, has prepared clinical practice guidelines (CPG) for dementia tailored to the Korean population. In this article, a summary of the CREDOS CPG is presented with the Korean and English version of full report included in the appendix. The CREDOS CPG in intended not only for psychiatrists and neurologists, but also internists, family physicians, and other primary care physicians involved in the prevention and early diagnosis of dementia. While our CPG for dementia mainly covers Alzheimer's disease (AD) and vascular dementia (VaD), it also includes mild cognitive impairment (MCI) and vascular MCI, which are currently known to be the preclinical stages of AD or VaD, respectively, with emphasis placed on early diagnosis. The CREDOS CPG aims to achieve the following goals by developing CPG for dementia: to establish evidence-based, objective and clear clinical standards for dementia; to improve the clinical decision-making process for patients with dementia; to provide scientific and systematic scales to aid in the work of dementia specialists; to suggest comprehensive and systematic healthcare services tailored to each dementia subtype. The CREDOS CPG focuses on diagnosis and evaluation of clinical practice available domestically, and provides useful concepts of dementia. Its emphasis is on etiologies and epidemiology, diagnostic criteria and evaluation, neuropsychological tests, behavioral and psychological symptoms, the activities of daily living, laboratory tests, and brain imaging.

Keywords

References

  1. Korea National Statistical Office. Social index survey. Daejeon: Korea National Statistical Office; 2006.
  2. Kim SY, Kim NS, Shin SS, Kim DW, Ji SM, Lee SJ. Manual for guideline adaptation ver 1.0. Cheongwon: Korea Centers for Disease Control and Prevention; 2009.
  3. Brainin M, Barnes M, Baron JC, Gilhus NE, Hughes R, Selmaj K, Waldemar G; Guideline Standards Subcommittee of the EFNS Scientific Committee. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces--revised recommendations 2004. Eur J Neurol 2004; 11:577-581. https://doi.org/10.1111/j.1468-1331.2004.00867.x
  4. National Collaborating Centre for Mental Health. Dementia: the NICE-SCIE guideline on supporting people with dementia and their carers in health and social care. London: British Psychological Society and Gaskell; 2007.
  5. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B; EFNS. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 2007;14:e1-26.
  6. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56: 1133-1142. https://doi.org/10.1212/WNL.56.9.1133
  7. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey- Bloom J, Relkin N, Small GW, Miller B, Stevens JC. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56: 1143-1153. https://doi.org/10.1212/WNL.56.9.1143
  8. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1154-1166. https://doi.org/10.1212/WNL.56.9.1154
  9. Scottish Intercollegiate Guidelines Network Management of patients with dementia: A national clinical guideline. Edinburgh: National Health Service, 2006.
  10. Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 1993;33:494-501. https://doi.org/10.1002/ana.410330513
  11. Jorm AF. Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 2000;46:219-227. https://doi.org/10.1159/000022163
  12. Gao S, Hendrie HC, Hall KS, Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry 1998;55:809-815. https://doi.org/10.1001/archpsyc.55.9.809
  13. Park J, Ko HJ, Park YN, Jung CH. Dementia among the elderly in a rural Korean community. Br J Psychiatry 1994;164:796-801. https://doi.org/10.1192/bjp.164.6.796
  14. Woo JI, Lee JH, Yoo KY, Kim CY, Kim YI, Shin YS. Prevalence estimation of dementia in a rural area of Korea. J Am Geriatr Soc 1998;46:983-987.
  15. Cho MJ, Hahm BJ, Jhoo JH, Bae JN, Kwon JS. Prevalence of cognitive impairment and depressive symptoms among the elderly in an urban community. J Korean Neuropsychiatr Assoc 1998;37:352-362.
  16. Kim DH, Na DL, Yeon BG, Kang Y, Min KB, Lee SH, Lee SS, Lee MR, Pyo OJ, Park CB, Kim S, Bae SS. Prevalence of dementia in the elderly of an urban community in Korea. Korean J Prev Med 1999;32:306-316.
  17. Suh GH. Epidemiologic transition in dementia-cross-national comparisons of the indices related to Alzheimer's disease and vascular dementia: epidemiologic transition in dementia. J Korean Geriatr Psychiatry 2000;4:173-185.
  18. Lee DY, Lee JH, Ju YS, Lee KU, Kim KW, Jhoo JH, Yoon JC, Ha J, Woo JI. The prevalence of dementia in older people in an urban population of Korea: the Seoul study. J Am Geriatr Soc 2002;50:1233-1239. https://doi.org/10.1046/j.1532-5415.2002.50310.x
  19. Kim J, Jeong I, Chun JH, Lee S. The prevalence of dementia in a metropolitan city of South Korea. Int J Geriatr Psychiatry 2003;18:617-622. https://doi.org/10.1002/gps.897
  20. Seoul National University Hospital. Nationwide study on the prevalence of dementia in Korean elders. Seoul: Ministry for Health, Welfare and Family Affairs; 2008.
  21. Daly E, Zaitchik D, Copeland M, Schmahmann J, Gunther J, Albert M. Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol 2000;57:675-680. https://doi.org/10.1001/archneur.57.5.675
  22. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991;41:1006- 1009. https://doi.org/10.1212/WNL.41.7.1006
  23. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308. https://doi.org/10.1001/archneur.56.3.303
  24. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992. https://doi.org/10.1001/archneur.58.12.1985
  25. Rocca WA, Hofman A, Brayne C, Breteler MM, Clarke M, Copeland JR, Dartigues JF, Engedal K, Hagnell O, Heeren TJ. Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence fin-dings. The EURODEM-Prevalence Research Group. Ann Neurol 1991; 30:381-390. https://doi.org/10.1002/ana.410300310
  26. Rabe A, Wisniewski KE, Schapf N, Wisniewski HE. Relationship of Down's syndrome to Alzheimer's disease. In: Deutsch SI, Weizman A, Weizman R, editors. Application of basic neuroscience to child. New York: Plenum Publishing; 1990. p. 325-339.
  27. Hardy J. New insights into the genetics of Alzheimer's disease. Ann Med 1996;28:255-258. https://doi.org/10.3109/07853899609033127
  28. Schellenberg GD, Anderson L, O'dahl S, Wisjman EM, Sadovnick AD, Ball MJ, Larson EB, Kukull WA, Martin GM, Roses AD. APP717, APP693, and PRIP gene mutations are rare in Alzheimer disease. Am J Hum Genet 1991;49:511-517.
  29. Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, Sherrington R, Hutton M, Hardy J, St George-Hyslop PH, Hofman A, Van Broeckhoven C. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 1998;7:43-51. https://doi.org/10.1093/hmg/7.1.43
  30. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: highavidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:1977-1981. https://doi.org/10.1073/pnas.90.5.1977
  31. Letenneur L. Risk of dementia and alcohol and wine consumption: a review of recent results. Biol Res 2004;37:189- 193.
  32. Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, van Duijn CM, Breteler MM. Smoking and risk of dementia and Alzheimer's disease in a populationbased cohort study: the Rotterdam Study. Lancet 1998;351: 1840-1843. https://doi.org/10.1016/S0140-6736(97)07541-7
  33. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556- 1560. https://doi.org/10.1001/archneur.62.10.1556
  34. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347: 1141-1145. https://doi.org/10.1016/S0140-6736(96)90608-X
  35. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000;356:1627-1631. https://doi.org/10.1016/S0140-6736(00)03155-X
  36. Guo Z, Cupples LA, Kurz A, Auerbach SH, Volicer L, Chui H, Green RC, Sadovnick AD, Duara R, DeCarli C, Johnson K, Go RC, Growdon JH, Haines JL, Kukull WA, Farrer LA. Head injury and the risk of AD in the MIRAGE study. Neurology 2000;54:1316-1323. https://doi.org/10.1212/WNL.54.6.1316
  37. Rovio S, Kareholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M. Leisuretime physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 2005;4:705-711. https://doi.org/10.1016/S1474-4422(05)70198-8
  38. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-1010. https://doi.org/10.1001/jama.1994.03510370056032
  39. De Craen AJ, Gussekloo J, Vrijsen B, Westendorp RG. Metaanalysis of nonsteroidal antiinflammatory drug use and risk of dementia. Am J Epidemiol 2005;161:114-120. https://doi.org/10.1093/aje/kwi029
  40. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337- 1342. https://doi.org/10.2105/AJPH.88.9.1337
  41. Kang IO, Park JY, Lee YK, Seo SR, Kim KH, Choi SJ. The socioeconomic cost analysis-oriented to the dementia patients using medical service. Seoul: National Health Insurance Cooperation; 2005.
  42. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-817. https://doi.org/10.1001/jama.1997.03540340047031
  43. American Psychiatry Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatry Association; 1994.
  44. World Health Organization. ICD 10: International Statistical Classification of Diseases and related health problems. 10th ed. Geneva: American Psychiatric Publishing; 1992.
  45. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944. https://doi.org/10.1212/WNL.34.7.939
  46. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260. https://doi.org/10.1212/WNL.43.2.250
  47. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488. https://doi.org/10.1002/ana.410070516
  48. Knopman DS, Parisi JE, Boeve BF, Cha RH, Apaydin H, Salviati A, Edland SD, Rocca WA. Vascular dementia in a populationbased autopsy study. Arch Neurol 2003;60:569-575. https://doi.org/10.1001/archneur.60.4.569
  49. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Mild cognitive impairment: beyond controversies, towards a consensus. Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246. https://doi.org/10.1111/j.1365-2796.2004.01380.x
  50. Hachinski V. Vascular dementia: a radical redefinition. Dementia 1994;5:130-132.
  51. Choi SH, Na DL, Kang Y, Lee WY, Park BJ. The validity and reliability of the Samsung Dementia Questionnaire (SDQ). J Korean Neurol Assoc 1998;16:307-314.
  52. Choi SH, Na DL, Oh KM, Park BJ. A Short form of the Samsung Dementia Questionnaire (S-SDQ): development and cross-validation. J Korean Neurol Assoc 1999;17:253-258.
  53. Yang DW, Cho BL, Chey JY, Kim SY, Kim BS. The development and validation of Korean Dementia Screening Questionnaire (KDSQ). J Korean Neurol Assoc 2002;20:135-141.
  54. Ryu HJ, Kim HJ, Han SH. Validity and reliability of the Korean version of the AD8 informant interview (K-AD8) in dementia. Alzheimer Dis Assoc Disord 2009;23:371-376. https://doi.org/10.1097/WAD.0b013e31819e6881
  55. Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, Miller JP, Storandt M, Morris JC. The AD8: a brief informant interview to detect dementia. Neurology 2005;65:559-564. https://doi.org/10.1212/01.wnl.0000172958.95282.2a
  56. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198. https://doi.org/10.1016/0022-3956(75)90026-6
  57. Kwon YC, Park JH. Korean version of Mini-Mental State Examination (MMSE-K) part : development of the test for the elderly. J Korean Neuropsychiatr Assoc 1989;28:125-135.
  58. Kang YW. A normative study of the Korean-Mini Mental State Examination (K-MMSE) in the elderly. Korean J Psychol 2006; 25:1-12.
  59. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, Lee KH, Kim SY, Han SH, Woo JI. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:P47-P53. https://doi.org/10.1093/geronb/57.1.P47
  60. Han JW, Kim TH, Jhoo JH, Park JH, Kim JL, Ryu SH, Moon SW, Choo IH, Lee DW, Yoon JC, Do YJ, Lee SB, Kim MD, Kim KW. A normative study of the Mini-Mental State Examination for Dementia Screening (MMSE-DS) and Its Short Form (SM MSE-DS) in the Korean elderly. J Korean Geriatr Psychiatry 2010;14:27-37.
  61. Choi SH, Na DL, Lee BH, Hahm DS, Jeong JH, Yoon SJ, Yoo KH, Ha CK, Han IW. Estimating the validity of the Korean version of expanded Clinical Dementia Rating (CDR) Scale. J Korean Neurol Assoc 2001;19:585-591.
  62. Choi SH, Na DL, Lee BH, Hahm DS, Jeong JH, Jeong Y, Koo EJ, Ha CK, Ahn SS, Korean Dementia Research Group. The validity of the Korean version of Global Deterioration Scale. J Korean Neurol Assoc 2002;20:612-617.
  63. Sohn EH, Lee AY, Park HJ. The validity and reliability of the Korean Modified Mini-Mental State (K-3MS) Examination. J Korean Neurol Assoc 2003;21:346-356.
  64. Kang YW, Na DL, Son KR, Chung CS, Lee KH. Comparison of two screening tests in dementia: the Mini-Mental State Examination (MMSE) and the revised Hasegawa's Demential Scale (HDS-R). J Korean Neurol Assoc 1999;17(Suppl 2):82-83.
  65. Yang DW, Kim BS, Shim DS, Chung SW, Lee KS, Han SH, Kim SY, Jeong SK. Reliability and validity of the Korean version of revised form of Hasegawa Dementia Scale (K-HDS). J Korean Neurol Assoc 2004;22:315-321.
  66. Kim KW, Lee DY, Ahn SY, Jhoo JH, Kil YN. Reliability and validity of the Korean version of Hasegawa Dementia Scale (HDS-K) as a dementia screening instrument. J Korean Neuropsychiatr Assoc 2002;41:526-537.
  67. Park MS, Cho BL, Yang DW, Kim SY. A validation study of a Korean version of the 7-minute screen test. J Korean Acad Fam Med 2002;23:728-739.
  68. Lee JY, Lee DW, Cho SJ, Na DL, Jeon HJ, Kim SK, Lee RA, Youn JH, Kwon M, Lee JH, Cho MJ. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol 2008;21:104-110. https://doi.org/10.1177/0891988708316855
  69. Kang YW, Park JS, Yu KH, Lee BC. A reliability validity, and normative study of the Korean-Montreal Cognitive Assessment (K-MoCA) as an instrument for screening of Vascular Cognitive Impairment (VCI). Korean J Clin Psychol 2009;28: 549-562.
  70. Kang YW, Na DL. Seoul neuropsychological screening battery. Incheon: Human Brain Research & Consulting Co.; 2003.
  71. Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, Na DL. Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci 2010; 25:1071-1076. https://doi.org/10.3346/jkms.2010.25.7.1071
  72. Youn JC, Lee DY, Kim KW, Lee JH, Jhoo JH, Lee KU, Ha J, Woo JI. Development of the Korean version of Alzheimer's Disease Assessment Scale (ADAS-K). Int J Geriatr Psychiatry 2002;17:797-803. https://doi.org/10.1002/gps.699
  73. Ahn IS, Kim JH, Ku HM, Saxton J, Kim DK. Reliability and validity of the severe impairment battery (SIB) in Korean dementia patients. J Korean Med Sci 2006;21:506-517. https://doi.org/10.3346/jkms.2006.21.3.506
  74. Na HR, Lee JW, Ko SB, Park SM, Lee SH, Yang DW, Han IW, Kim DH, Baek MJ, Lee JS, Kim JS, Kim SY. The validity and reliability of the Korean version of Severe Impairment Battery. Dement Neurocogn Disord 2006;5:70-76.
  75. Chey JY, Lee SA. Development of the norms for the Korean- Dementia Rating Scale. Korean J Clin Psychol 1997;16:423-433.
  76. Chey JY. Elderly memory disorder scale. Seoul: Hakjisa; 2007.
  77. Finkel S. Introduction to behavioural and psychological symptoms of dementia (BPSD). Int J Geriatr Psychiatry 2000; 15 Suppl 1:S2-S4.
  78. Choi SH, Na DL, Kwon HM, Yoon SJ, Jeong JH, Ha CK. The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients. J Korean Med Sci 2000;15:609-615.
  79. Suh GH, Park JH. The Behavior Pathology in Alzheimer's Disease Rating Scale, Korean version (BEHAVE-AD-K): factor structure among Alzheimer's disease inpatients. J Korean Geriatr Psychiatry 2001;5:86-95.
  80. Youn JC, Lee DY, Lee JH, Kim KW, Jhoo JH, Choo IH, Paek YS, Jeon YH, Seo KW, Woo JI. Development of a Korean version of the Behavior Rating Scale for Dementia (BRSD-K). Int J Geriatr Psychiatry 2008;23:677-684. https://doi.org/10.1002/gps.1960
  81. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965;14:61-65.
  82. Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H. The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord 1998;9 Suppl 2:20-26.
  83. Rubin EH, Kinscherf DA. Psychopathology of very mild dementia of the Alzheimer type. Am J Psychiatry 1989;146: 1017-1021.
  84. Galasko D, Kershaw PR, Schneider L, Zhu Y, Tariot PN. Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease. J Am Geriatr Soc 2004;52: 1070-1076. https://doi.org/10.1111/j.1532-5415.2004.52303.x
  85. Kang SJ, Choi SH, Lee BH, Kwon JC, Na DL, Han SH. The reliability and validity of the Korean Instrumental Activities of Daily Living (K-IADL). J Korean Neurol Assoc 2002;20:8-14.
  86. Choi SH, Na DL, Lee BH, Kang SJ, Ha CK, Han SH, Erzigkeit H. Validation of the Korean version of the Bayer Activities of Daily Living Scale. Hum Psychopharmacol 2003;18:469-475. https://doi.org/10.1002/hup.505
  87. Suh GH. Development of the Korean version of Disability Assessment for Dementia Scale (DAD-K) to assess function in dementia. J Korean Geriatr Soc 2003;7:278-287.
  88. Ku HM, Kim JH, Kwon EJ, Kim SH, Lee HS, Ko HJ, Jo S, Kim DK. A study on the reliability and validity of Seoul-Instrumental Activities of Daily Living (S-IADL). J Korean Neuropsychiatr Assoc 2004;43:189-199.
  89. Ku HM, Kim JH, Lee HS, Ko HJ, Kwon EJ, Jo S, Kim DK. A study on the reliability and validity of Seoul-Activities of Daily Living (S-ADL). J Korean Geriatr Soc 2004;8:206-214.
  90. Royal College of Psychiatrists. Forgetful but not forgotten. London: Royal College of Psychiatrists; 2005.
  91. Andreasen N, Blennow K. CSF biomarkers for mild cognitive impairment and early Alzheimer's disease. Clin Neurol Neurosurg 2005;107:165-173. https://doi.org/10.1016/j.clineuro.2004.10.011
  92. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924-930. https://doi.org/10.1056/NEJM199609263351303
  93. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003;2:605-613. https://doi.org/10.1016/S1474-4422(03)00530-1
  94. Verbeek MM, De Jong D, Kremer HP. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases. Ann Clin Biochem 2003;40(Pt 1):25-40.
  95. Strozyk D, Blennow K, White LR, Launer LJ. CSF Abeta 42 levels correlate with amyloid-neuropathology in a populationbased autopsy study. Neurology 2003;60:652-656. https://doi.org/10.1212/01.WNL.0000046581.81650.D0
  96. Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Crain B, Tang MX, Phelps CH. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med 1998;338: 506-511. https://doi.org/10.1056/NEJM199802193380804
  97. De Leon MJ, Convit A, DeSanti S, Bobinski M, George AE, Wisniewski HM, Rusinek H, Carroll R, Saint Louis LA. Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease. Int Psychogeriatr 1997;9 Suppl 1:183-190.
  98. Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, Di Chiro G. Cortical abnormalities in Alzheimer's disease. Ann Neurol 1984;16:649-654. https://doi.org/10.1002/ana.410160605
  99. Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, Cole GM, Small GW, Huang SC, Barrio JR. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci 2001;21:RC189.

Cited by

  1. 일개 보건소 한의약 경도인지장애 관리프로그램의 효과분석 vol.34, pp.3, 2011, https://doi.org/10.13048/jkm.13016
  2. The Association of Gait Disturbance and Cognitive Impairment vol.12, pp.4, 2011, https://doi.org/10.12779/dnd.2013.12.4.94
  3. 한방정신요법 및 치매 검사의 현황, 수가 적절성 연구 vol.25, pp.4, 2011, https://doi.org/10.7231/jon.2014.25.4.411
  4. Assessment of Dementia vol.8, pp.1, 2011, https://doi.org/10.12786/bn.2015.8.1.11
  5. 치매의 한열허실 변증 지표문항에 대한 예비분석 vol.26, pp.3, 2011, https://doi.org/10.7231/jon.2015.26.3.283
  6. Adaptation of a Translated Guideline on Screening for Delirium, Dementia, and Depression in Older Adults vol.17, pp.2, 2011, https://doi.org/10.17079/jkgn.2015.17.2.76
  7. Experience of Dementia-related Anxiety in Middle-aged Female Caregivers for Family Members with Dementia: A Phenomenological Study vol.10, pp.2, 2011, https://doi.org/10.1016/j.anr.2016.02.001
  8. The Effect of Dangguijagyag-san on Mild Cognitive Impairment vol.22, pp.7, 2011, https://doi.org/10.1089/acm.2015.0261
  9. 소그룹 인지기능강화 프로그램이 인지기능, 일상생활활동, 우울, 생활만족도, 악력에 미치는 영향 vol.23, pp.3, 2011, https://doi.org/10.5953/jmjh.2016.23.3.169
  10. 한의학 병리적 노화 척도와 치매 한의학적 변증진단 개발 및 신뢰도 평가 vol.38, pp.3, 2011, https://doi.org/10.13048/jkm.17030
  11. Social Network Analysis on Mapping the Knowledge Structure of Dementia Research vol.19, pp.2, 2011, https://doi.org/10.17079/jkgn.2017.19.2.69
  12. Literature Review on Necessity of Occupational Therapist as Member of Early Screening Team at Center for Dementia Safety vol.27, pp.2, 2011, https://doi.org/10.14519/kjot.2019.27.2.03
  13. 지역사회 노인에서의 수면의 질과 인지기능의 관련성에 대한 연구 vol.27, pp.1, 2011, https://doi.org/10.14401/kasmed.2020.27.1.16
  14. Validation of Four Methods for Converting Scores on the Montreal Cognitive Assessment to Scores on the Mini-Mental State Examination-2 vol.20, pp.4, 2011, https://doi.org/10.12779/dnd.2021.20.4.41
  15. A Deep Neural Network-Based Method for Prediction of Dementia Using Big Data vol.18, pp.10, 2021, https://doi.org/10.3390/ijerph18105386
  16. Automated Classification of Normal Control and Early-Stage Dementia Based on Activities of Daily Living (ADL) Data Acquired from Smart Home Environment vol.18, pp.24, 2011, https://doi.org/10.3390/ijerph182413235